GENERAL BIOLOGICALS CORPORATION General Biologicals Corporation Stock
Equities
4117
TW0004117007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.6 TWD | -1.67% |
|
-3.29% | -23.70% |
| Sales 2022 | 370M 11.47M | Sales 2023 | 265M 8.2M | Capitalization | 1.62B 49.99M |
|---|---|---|---|---|---|
| Net income 2022 | -53M -1.64M | Net income 2023 | -199M -6.16M | EV / Sales 2022 | 4.66 x |
| Net Debt 2022 | 118M 3.64M | Net Debt 2023 | 331M 10.26M | EV / Sales 2023 | 7.35 x |
| P/E ratio 2022 |
-30.2
x | P/E ratio 2023 |
-8.12
x | Employees | 81 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.67% | ||
| 1 week | -3.29% | ||
| Current month | -2.37% | ||
| 1 month | -4.63% | ||
| 3 months | -10.43% | ||
| 6 months | -26.69% | ||
| Current year | -23.70% |
1 week
20.40
21.10
1 month
19.4022.30
Current year
19.4027.95
1 year
19.4030.20
3 years
18.5065.10
5 years
5.71278.00
10 years
5.71278.00
| Managers | Title | Age | Since |
|---|---|---|---|
Meng Te Lin
CEO | Chief Executive Officer | - | 13-07-14 |
En Jung Tsao
DFI | Director of Finance/CFO | - | - |
Meng Hui Lin
PRN | Corporate Officer/Principal | - | 13-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming-Chih Hsuan
BRD | Director/Board Member | 70 | 10-06-23 |
Tsung Ching Lin
CHM | Chairman | - | 89-05-24 |
Pi Hua Chen
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 20.6 | -1.67% | 43,039 |
| 24-05-27 | 20.95 | -0.24% | 41,457 |
| 24-05-24 | 21 | +0.96% | 19,855 |
| 24-05-23 | 20.8 | -0.95% | 12,117 |
| 24-05-22 | 21 | -1.41% | 72,743 |
End-of-day quote Taipei Exchange, May 27, 2024
More quotes
GENERAL BIOLOGICALS CORP. is a Taiwan-based company principally engaged in the design, development, manufacture, sales and import and export trading of diagnostic kits and auxiliary equipment, as well as the provision of medical technology services. The Company's main products include detection reagents, biological protein new drug, P113, and medical supplies. The Company distributes its products in domestic market and to overseas markets.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.70% | 38.28M | |
| -6.76% | 12.1B | |
| -4.07% | 8.14B | |
| +6.33% | 5.72B | |
| +28.13% | 5.51B | |
| -59.44% | 2.72B | |
| +8.04% | 2.59B | |
| -8.42% | 2.34B | |
| +21.84% | 2.11B | |
| -8.15% | 1.79B |
- Stock Market
- Equities
- 4117 Stock
